Search Results

There are 5597 results for: content related to: Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection

  1. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  2. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  3. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27516

  4. You have free access to this content
    JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2

    Hepatology Research

    Volume 46, Issue 2, February 2016, Pages: 129–165, Yasuhiro Asahina, Namiki Izumi, Kumada Hiromitsu, Masayuki Kurosaki, Kazuhiko Koike, Fumitaka Suzuki, Hajime Takikawa, Atsushi Tanaka, Eiji Tanaka, Yasuhito Tanaka, Hirohito Tsubouchi, Norio Hayashi, Naoki Hiramatsu and Hiroshi Yotsuyanagi

    Version of Record online : 15 FEB 2016, DOI: 10.1111/hepr.12645

  5. You have free access to this content
    Poster Session 4: Hepatitis C: New Agents (Not Approved)

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1128A–1161A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27533

  6. Relative blood volume measurements during hemodialysis: Comparisons between three noninvasive devices

    Hemodialysis International

    Volume 11, Issue 4, October 2007, Pages: 448–455, Judith J. DASSELAAR, Roel M. HUISMAN, Paul E. DE JONG and Casper F.M. FRANSSEN

    Version of Record online : 5 OCT 2007, DOI: 10.1111/j.1542-4758.2007.00216.x

  7. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue s2, May 2012, Pages: 1–26, I. M. Jacobson, J.-M. Pawlotsky, N. H. Afdhal, G. M. Dusheiko, X. Forns, D. M. Jensen, F. Poordad and J. Schulz

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01590.x

  8. The RBV theory foundation of strategic HRM: critical flaws, problems for research and practice, and an alternative economics paradigm

    Human Resource Management Journal

    Volume 25, Issue 4, November 2015, Pages: 516–540, Bruce E. Kaufman

    Version of Record online : 24 SEP 2015, DOI: 10.1111/1748-8583.12085

  9. You have free access to this content
    Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 6, September 2014, Pages: 657–675, S. Saab, S. C. Gordon, H. Park, M. Sulkowski, A. Ahmed and Z. Younossi

    Version of Record online : 28 JUL 2014, DOI: 10.1111/apt.12871

  10. Optimal dose of peginterferon and ribavirin for treatment of chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 15, Issue 9, September 2008, Pages: 623–633, M. Gambarin-Gelwan and I. M. Jacobson

    Version of Record online : 10 JUL 2008, DOI: 10.1111/j.1365-2893.2008.01018.x

  11. You have free access to this content
    A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results

    Hepatology

    Volume 50, Issue 3, September 2009, Pages: 717–726, Yves Benhamou, Nezam H. Afdhal, David R. Nelson, Mitchell L. Shiffman, Deanine G. Halliman, Jamie Heise, Eric Chun and Paul J. Pockros

    Version of Record online : 11 MAY 2009, DOI: 10.1002/hep.23073

  12. Effects of ribavirin monotherapy on the viral population in patients with chronic hepatitis C genotype 1: Direct sequencing and pyrosequencing of the HCV regions

    Journal of Medical Virology

    Volume 86, Issue 11, November 2014, Pages: 1886–1897, R. Quiles-Pérez, P. Muñoz-de-Rueda, A. Martín-Lagos Maldonado, A. Martín-Álvarez, J. Quer and J. Salmerón

    Version of Record online : 5 AUG 2014, DOI: 10.1002/jmv.24035

  13. Macromolecular Prodrugs for Controlled Delivery of Ribavirin

    Macromolecular Bioscience

    Volume 14, Issue 2, February 2014, Pages: 173–185, Mille B. L. Kryger, Anton A. A. Smith, Benjamin M. Wohl and Alexander N. Zelikin

    Version of Record online : 17 SEP 2013, DOI: 10.1002/mabi.201300244

  14. You have free access to this content
    HCV Therapeutics: New Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 730A–760A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26858

  15. Resource Immobility and Sustained Performance: A Systematic Assessment of How Immobility Has Been Considered in Empirical Resource-based Studies

    International Journal of Management Reviews

    Jim Andersén, Christian Jansson and Torbjörn Ljungkvist

    Version of Record online : 11 MAY 2015, DOI: 10.1111/ijmr.12067

  16. You have free access to this content
    Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C

    Hepatology

    Volume 52, Issue 4, October 2010, Pages: 1208–1215, Fred Poordad, Eric Lawitz, Mitchell L. Shiffman, Tarek Hassanein, Andrew J. Muir, Bruce R. Bacon, Jamie Heise, Deanine Halliman, Eric Chun and Janet Hammond

    Version of Record online : 30 JUN 2010, DOI: 10.1002/hep.23827

  17. Therapy for hepatitis C genotype 3: moving forward

    Journal of Viral Hepatitis

    Volume 22, Issue 9, September 2015, Pages: 683–690, M. Buti, J. Llaneras, M. Riveiro-Barciela and R. Esteban

    Version of Record online : 13 MAY 2015, DOI: 10.1111/jvh.12419

  18. Impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapy

    Journal of Medical Virology

    Volume 88, Issue 10, October 2016, Pages: 1776–1784, Yuki Tahata, Naoki Hiramatsu, Tsugiko Oze, Ayako Urabe, Naoki Morishita, Ryoko Yamada, Takayuki Yakushijin, Atsushi Hosui, Masahide Oshita, Akira Kaneko, Hideki Hagiwara, Eiji Mita, Toshifumi Ito, Yukinori Yamada, Masami Inada, Kazuhiro Katayama, Shinji Tamura, Yasuharu Imai, Hayato Hikita, Ryotaro Sakamori, Yuichi Yoshida, Tomohide Tatsumi, Norio Hayashi and Tetsuo Takehara

    Version of Record online : 29 MAR 2016, DOI: 10.1002/jmv.24528

  19. Increase in platelet count based on inosine triphosphatase genotype during interferon beta plus ribavirin combination therapy

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 9, September 2012, Pages: 1461–1466, Hideyuki Nomura, Yugo Miyagi, Hironori Tanimoto, Nobuyuki Yamashita, Kiyoaki Ito, Naohiko Masaki and Masashi Mizokami

    Version of Record online : 21 AUG 2012, DOI: 10.1111/j.1440-1746.2012.07171.x

  20. You have free access to this content
    Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

    Hepatology

    Volume 62, Issue 3, September 2015, Pages: 932–954, AASLD/IDSA HCV Guidance Panel

    Version of Record online : 4 AUG 2015, DOI: 10.1002/hep.27950